Charles River Laboratories International Inc (CRL)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Charles River Laboratories International Inc (CRL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011386
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The organization also offers clinical support, manufacturing support and operations and staffing support. It focuses on providing solutions targeted against therapeutic areas of cardiovascular, central nervous system, metabolic inflammation, oncology, ophthalmology, respiratory disease and musculoskeletal disease. Charles River caters its products and services to global pharmaceutical companies, biotechnology companies, government agencies, as well as leading hospitals and academic institutions, and operates through a network facilities located worldwide. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc (CRL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Charles River Laboratories International Inc, Medical Equipment, Deal Details 12
Partnerships 12
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson’s Disease 17
Charles River Labs Enters Into Agreement With Bruker For Axcess System 18
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 19
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson’s Disease 20
BioFocus Enters Into An Agreement With Almac Group 21
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 22
Asset Transactions 23
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Acquisition 24
Charles River Labs Acquires Celsis International for USD214.5 Million 24
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For US$17 Million 25
Charles River Laboratories International Inc – Key Competitors 26
Charles River Laboratories International Inc – Key Employees 27
Charles River Laboratories International Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 33
Financial Announcements 33
Nov 09, 2017: Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations 33
Aug 09, 2017: Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations 35
May 10, 2017: Charles River Laboratories Announces First-Quarter 2017 Results from Continuing Operations 37
Feb 14, 2017: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance 39
Nov 02, 2016: Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing Operations 42
Aug 03, 2016: Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations 44
May 04, 2016: Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations 46
Feb 10, 2016: Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance 48
Corporate Communications 51
Jul 05, 2017: Charles River Laboratories Adds Martin Mackay, Ph.D. to Board of Directors 51
Product News 52
Nov 01, 2017: Charles River Laboratories Presents Newly Expanded Capabilities at Neuroscience 2017 52
Other Significant Developments 54
Dec 06, 2017: Charles River Adds ERS License to CRISPR/Cas9 Service Offering 54
Jun 28, 2017: SenzaGen signs global distribution agreement with Charles River Laboratories 55
May 16, 2017: Charles River Laboratories Announces Updates to Oncology Business 56
Sep 29, 2016: PathoQuest Announces Partnership with Charles River Laboratories 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Charles River Laboratories International Inc, Medical Equipment, Key Facts, 2016 2
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Charles River Laboratories International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Charles River Laboratories International Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Charles River Laboratories International Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Charles River Laboratories International Inc, Deals By Market, 2011 to YTD 2017 9
Charles River Laboratories International Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Charles River Lab Enters into Licensing Agreement with ERS Genomics 12
InSphero to Enter into Licensing Agreement with Charles River Labs 13
SenzaGen Enters into Distribution Agreement with Charles River Laboratories 14
Charles River Labs Expands Agreement with OcellO 15
Molecular Imaging Enters into Co-Promotion Agreement with Oncotest 16
BioFocus Extends Agreement With Michael J. Fox Foundation For Parkinson's Disease 17
Charles River Labs Enters Into Agreement With Bruker For Axcess System 18
Reinnervate Enters Into Co-Marketing Agreement With Oncotest For Alvetex Scaffold Technology 19
BioFocus Enters Into Agreement With Michael J. Fox Foundation For Parkinson's Disease 20
BioFocus Enters Into An Agreement With Almac Group 21
ChanTest Corporation Enters Into Co-Marketing Agreement With Molecular Devices 22
AAIPharma Services Acquires Celsis Analytical Services From Celsis International 23
Charles River Labs Acquires Celsis International for USD214.5 Million 24
Charles River Labs Acquires Accugenix, Provider Of Microbe Identification Services, For US$17 Million 25
Charles River Laboratories International Inc, Key Competitors 26
Charles River Laboratories International Inc, Key Employees 27
Charles River Laboratories International Inc, Subsidiaries 29

★海外企業調査レポート[Charles River Laboratories International Inc (CRL)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OrthoPediatrics Corp (KIDS):医療機器:M&Aディール及び事業提携情報
    Summary OrthoPediatrics Corp (OrthoPediatrics) is a medical device company that designs, develops and distributes implants and instruments. The company offers trauma and deformity, spine, sports medicine, and clinical education products. It provides cannulated screws, spine system, ACL reconstructio …
  • Alterity Therapeutics Ltd (PBT):企業の財務・戦略的SWOT分析
    Summary Alterity Therapeutics Ltd (Alterity Therapeutics) formerly known as Prana Biotechnology Ltd, is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease, brain cancer and other major age-related degenerative disorders. It is developing …
  • Dynasil Corporation of America (DYSL)-医療機器分野:企業M&A・提携分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company also offers optical detection and analysis technology and components. It provides products such as beamsplitters, diffraction gratings, infrar …
  • eHealthInsurance Services Inc:企業の戦略的SWOT分析
    eHealthInsurance Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Oiltanking GmbH:石油・ガス:M&Aディール及び事業提携情報
    Summary Oiltanking GmbH (Oiltanking), a subsidiary of Marquard & Bahls AG is an independent tank storage service provider. The company offers storage facilities and associated services for oils, petroleum products, chemicals, biofuels, gases and dry bulk. It owns and operates terminals in Europe, No …
  • Gujarat State Electricity Corporation Ltd:企業の戦略的SWOT分析
    Gujarat State Electricity Corporation Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • TransGlobe Energy Corp (TGL):石油・ガス:M&Aディール及び事業提携情報
    Summary TransGlobe Energy Corp (TransGlobe Energy) is an oil and gas company that explores, develops and produces crude oil and natural gas. The company develops oil and natural gas properties in the Arab Republic of Egypt and the Republic of Yemen. It holds interests in various production sharing c …
  • Portland General Electric Co (POR)-エネルギー分野:企業M&A・提携分析
    Summary Portland General Electric Company (PGE) is a vertically integrated electric utility which generates, transmits, distributes, and retails electricity. The company generates electricity from wholly and jointly owned wind, natural gas, coal and hydroelectric plants. PGE also participates in the …
  • aap Implantate AG (AAQ):医療機器:M&Aディール及び事業提携情報
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • University of California Berkeley-製薬・医療分野:企業M&A・提携分析
    Summary University of California Berkeley (UC Berkeley), a subsidiary of University of California is an educational university that offers educational programs and research services. The university’s academic programs comprise law and economics program, legal studies; lesbian, gay, bisexual, and tra …
  • AB-Biotics SA (ABB)-製薬・医療分野:企業M&A・提携分析
    Summary AB-Biotics SA (AB-Biotics) is a provider of probiotics, specialty dietary supplements, pipeline products and other functional ingredients. The company’s products comprise probiotic products, iron-containing ingredients, lactobacillus plantarum, lactobacillus brevis, natural solutions, gastro …
  • Ascendis Pharma AS (ASND):医療機器:M&Aディール及び事業提携情報
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Cooper Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Cooper Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Cooper Energy Limited (CEL) is an exploration and production company that offers oil production programs. The company explores, produces, and commercializes crude oil and natural gas products. It condu …
  • Hanesbrands Inc.:企業の戦略・SWOT・財務情報
    Hanesbrands Inc. - Strategy, SWOT and Corporate Finance Report Summary Hanesbrands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Caja Laboral Popular Coop. de Credito:企業の戦略・SWOT・財務情報
    Caja Laboral Popular Coop. de Credito - Strategy, SWOT and Corporate Finance Report Summary Caja Laboral Popular Coop. de Credito - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Metro AG:企業の戦略・SWOT・財務情報
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Anika Therapeutics Inc (ANIK)-製薬・医療分野:企業M&A・提携分析
    Summary Anika Therapeutics Inc (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products i …
  • Natco Pharma Ltd (NATCOPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, i …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Trafigura Group Pte Ltd:企業の戦略的SWOT分析
    Trafigura Group Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆